SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-23-042500
Filing Date
2023-11-22
Accepted
2023-11-22 16:15:57
Documents
6

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 546479
2 ex4-6.htm EX-4.6 475760
3 ex4-7.htm EX-4.7 483099
4 ex5-1.htm EX-5.1 29886
5 ex23-1.htm EX-23.1 3016
6 ex107.htm EX-FILING FEES 103350
  Complete submission text file 0001493152-23-042500.txt   1642639
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275716 | Film No.: 231433690
SIC: 2834 Pharmaceutical Preparations